ClinicalTrials.gg
Drug

Zanamivir clinical trials

Also written Relenza.

studies test it
16
open now
2
in phase 3
6
first study started
2007

How each study uses Zanamivir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Zanamivir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 Jul 1999 · RELENZA · NDA 021036 (FDA, Drugs@FDA)
European Union
26 Apr 2019 · Dectova · EMEA/H/C/004102 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Zanamivir
11

Brand

Relenza
5

In one entry with another drug

Given together, or one or the other

oseltamivir + zanamivir
2

Studies by the year they started

16 studies that test it; most in 2009 (4)

Studies that test Zanamivir, by start year
YearStudies
20071
20082
20094
20113
20121
20151
20211
20221
20231
20241

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
5
Phase 3
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 8

GlaxoSmithKline (7) · University of Missouri-Columbia (1) · Mount Sinai Hospital, Canada (1) · Jiangsu Simcere Pharmaceutical Co., Ltd. (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · George Washington University (1) · University of Oxford (1) · Assistance Publique - Hôpitaux de Paris (1)

Often tested with

Tested in the same studies.

Oseltamivir (6) · Influenza Vaccines (1) · Favipiravir (1) · Baloxavir (1) · Molnupiravir (1) · Peramivir (1) · Laninamivir (1) · Amantadine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test Zanamivir.

Studies

Open first, then newest update. How each study uses Zanamivir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 16

As the comparator · 1 — what is tested is compared with Zanamivir

Codes

What other systems call Zanamivir · ClinicalTrials.gg INT008881

  • MeSH (NLM) D053243ZanamivirConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) L6O3XI777IZANAMIVIRConfirmed FDA, NLM, Wikidata
  • RxNorm 69722Confirmed FDA, Wikidata
  • Wikidata Q146075zanamivirConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C47786ZanamivirOne source FDA
  • DrugBank DB00558One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.